Moderna, Inc. (MRNA)

Nasdaq · Healthcare · Biotechnology
$195.00-2.17%As of 2026-11-22 · USD
Last session low $191.46Last session high $210.00
52-week low $23.5552-week high $280.80
Market cap
$78.90B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)41.5In the neutral range (30 to 70)
MACD (12, 26, 9)-1.07Below its signal line (6.26); histogram -7.33
Bollinger %B (20, 2)15%Inside the bands (182.18 to 268.44)
SMA 20225.31Price is 13.5% below
SMA 50207.91Price is 6.2% below
SMA 200100.42Price is 94.2% above
ATR (20)9.28% of priceAverage true range per day
52-week position67%In the middle of the 23.55 to 280.80 range

About Moderna, Inc.

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Insider filings, 90 daysNo purchases and 8 sales (about $50.8M).
Latest fiscal yearEnded 2025-12-31: revenue of $1.92B and an operating margin of -159.9%.

More in Biotechnology